Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Revenue

Orchid Pharma had revenue of 2.07B INR in the quarter ending December 31, 2025, a decrease of -4.64%. This brings the company's revenue in the last twelve months to 8.11B, down -10.02% year-over-year. In the fiscal year ending March 31, 2025, Orchid Pharma had annual revenue of 9.22B with 12.52% growth.

• Revenue (ttm): 8.11B
• Revenue Growth: -10.02%
• P/S Ratio: 4.40
• Revenue / Employee: 11.02M
• Employees: 736
• Market Cap: 35.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	9.22B	1.03B	12.52%
Mar 31, 2024	8.19B	1.53B	23.05%
Mar 31, 2023	6.66B	1.06B	19.00%
Mar 31, 2022	5.60B	1.09B	24.33%
Mar 31, 2021	4.50B	-337.41M	-6.97%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error